Neuroscience Bulletin

, Volume 28, Issue 5, pp 493–498 | Cite as

Neurotrophic effects of 7,8-dihydroxycoumarin in primary cultured rat cortical neurons

  • Li Yan
  • Xiaowen Zhou
  • Xing Zhou
  • Zheng Zhang
  • Huan-Min LuoEmail author
Original Article



Neuronal loss in the central nervous system is central to the occurrence of neurodegenerative diseases. Pharmaceutical companies have devoted much effort to developing new drugs against such diseases, since there are currently no effective drugs for neurodegenerative disease treatment. Promoting the capacity for nerve regeneration is an ideal treatment target. The present study aimed to investigate the neurotrophic effects of 7,8-dihydroxycoumarin (DHC) or daphnetin in primary cultured rat cortical neurons.


Cortical neurons were identified by microtubule-associated protein 2 (MAP2) immunostaining. Morphological observation was used to measure the average length of neurite outgrowth. MTT and lactate dehydrogenase assays were used to assess neuronal survival. The mRNA expression of MAP2 and brain-derived neurotrophic factor (BDNF) was measured by RT-PCR.


MAP2 immunostaining showed that most of the cultured cells were neurons. Compared with the vehicle control group, DHC promoted neurite outgrowth and prolonged neuronal survival time at concentrations ranging from 2 to 8 μmol/L. Expression of both BDNF mRNA and MAP2 mRNA was increased in the groups treated with 2, 4 and 8 μmol/L DHC.


DHC significantly increases neurite outgrowth and promotes neuronal survival in primary cultured rat cortical neurons. The neurotrophic effects of DHC are probably associated with increased BDNF expression.


7,8-dihydroxycoumarin daphnetin rat cortical neurons brain-derived neurotrophic factor neurodegenerative disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. [1]
    Zhai H, Inoue T, Moriyama M, Esumi T, Mitsumoto Y, Fukuyama Y. Neuroprotective effects of 2,5-diaryl-3,4-dimethyltetrahydrofuran neolignans. Biol Pharm Bull 2005, 28: 289–293.PubMedCrossRefGoogle Scholar
  2. [2]
    Zhai H, Nakatsukasa M, Mitsumoto Y, Fukuyama Y. Neurotrophic effects of talaumidin, a neolignan from Aristolochia arcuata, in primary cultured rat cortical neurons. Planta Med 2004, 70: 598–602.PubMedCrossRefGoogle Scholar
  3. [3]
    Esumi T, Makado G, Zhai HF, Shimizu Y, Mitsumoto Y, Fukuyama Y. Efficient synthesis and structure-activity relationship of honokiol, a neurotrophic biphenyl-type neolignan. Bioorg Med Chem Lett 2004, 14: 2621–2625.PubMedCrossRefGoogle Scholar
  4. [4]
    Zhou GX, Yang YC, Shi JG. Study of chemical constituents in stem rind of Daphne giraldii. Zhongguo Zhong Yao Za Zhi 2006, 31: 555–557. (in Chinese)PubMedGoogle Scholar
  5. [5]
    Ma XC, Li FY, Gou ZP, Tian Y, Tian G, Wang CY, et al. Preparative isolation and purification of two phenylpropanoids from Daphne giraldii Nitsche by HSCCC. Chromatographia 2010, 71: 481–485.CrossRefGoogle Scholar
  6. [6]
    Gao Q, Shan J, Di L, Jiang L, Xu H. Therapeutic effects of daphnetin on adjuvant-induced arthritic rats. J Ethnopharmacol 2008, 120: 259–263.PubMedCrossRefGoogle Scholar
  7. [7]
    Yang YZ, Ranz A, Pan HZ, Zhang ZN, Lin XB, Meshnick SR. Daphnetin: a novel antimalarial agent with in vitro and in vivo activity. Am J Trop Med Hyg 1992, 46: 15–20.PubMedGoogle Scholar
  8. [8]
    Fylaktakidou KC, Hadjipavlou-Litina DJ, Litinas KE, Nicolaides DN. Natural and synthetic coumarin derivatives with anti-inflammatory/antioxidant activities. Curr Pharm Des 2004, 10: 3813–3833.PubMedCrossRefGoogle Scholar
  9. [9]
    Cottiglia F, Loy G, Garau D, Floris C, Casu M, Pompei R, et al. Antimicrobial evaluation of coumarins and flavonoids from the stems of Daphne gnidium L. Phytomedicine 2001, 8: 302–305.PubMedCrossRefGoogle Scholar
  10. [10]
    Huang F, Tang LH, Yu LQ, Ni YC, Wang QM, Nan FJ. In vitro potentiation of antimalarial activities by daphnetin derivatives against Plasmodium falciparum. Biomed Environ Sci 2006, 19: 367–370.PubMedGoogle Scholar
  11. [11]
    Chen CJ, Liao SL. Neurotrophic and neurotoxic effects of zinc on neonatal cortical neurons. Neurochem Int 2003, 42: 471–479.PubMedCrossRefGoogle Scholar
  12. [12]
    Matsui N, Nakashima H, Ushio Y, Tada T, Shirono T, Fukuyama Y, et al. Neurotrophic effect of magnolol in the hippocampal CA1 region of senescence-accelerated mice (SAMP1). Biol Pharm Bull 2005, 28: 1762–1765.PubMedCrossRefGoogle Scholar
  13. [13]
    Zhai H, Nakade K, Oda M, Mitsumoto Y, Akagi M, Sakurai J, et al. Honokiol-induced neurite outgrowth promotion depends on activation of extracellular signal-regulated kinases (ERK1/2). Eur J Pharmacol 2005, 516: 112–117.PubMedCrossRefGoogle Scholar
  14. [14]
    Mandelkow E, Mandelkow EM. Microtubules and microtubule-associated proteins. Curr Opin Cell Biol 1995, 7: 72–81.PubMedCrossRefGoogle Scholar
  15. [15]
    Somenarain L, Jones LB. A comparative study of MAP2 immunostaining in areas 9 and 17 in schizophrenia and Huntington chorea. J Psychiatr Res 2010, 44: 694–699.PubMedCrossRefGoogle Scholar
  16. [16]
    Yang Y, Constance BH, Deymier PA, Hoying J, Raghavan S, Zelinski BJJ. Electroless metal plating of microtubules: Effect of microtubule-associated proteins. J Mater Sci 2004, 39: 1927–1933.CrossRefGoogle Scholar
  17. [17]
    Zigova T, Pencea V, Wiegand SJ, Luskin MB. Intraventricular administration of BDNF increases the number of newly generated neurons in the adult olfactory bulb. Mol Cell Neurosci 1998, 11: 234–245.PubMedCrossRefGoogle Scholar
  18. [18]
    Zuccato C, Cattaneo E. Brain-derived neurotrophic factor in neurodegenerative diseases. Nat Rev Neurol 2009, 5: 311–322.PubMedCrossRefGoogle Scholar
  19. [19]
    Ferrer I, Goutan E, Marin C, Rey MJ, Ribalta T. Brain-derived neurotrophic factor in Huntington disease. Brain Res 2000, 866: 257–261.PubMedCrossRefGoogle Scholar
  20. [20]
    Bekinschtein P, Cammarota M, Katche C, Slipczuk L, Rossato JI, Goldin A, et al. BDNF is essential to promote persistence of long-term memory storage. Proc Natl Acad Sci U S A 2008, 105: 2711–2716.PubMedCrossRefGoogle Scholar
  21. [21]
    Zuccato C, Cattaneo E. Role of brain-derived neurotrophic factor in Huntington’s disease. Prog Neurobiol 2007, 81: 294–3PubMedCrossRefGoogle Scholar

Copyright information

© Shanghai Institutes for Biological Sciences, CAS and Springer-Verlag Berlin Heidelberg 2012

Authors and Affiliations

  • Li Yan
    • 1
  • Xiaowen Zhou
    • 1
  • Xing Zhou
    • 1
  • Zheng Zhang
    • 1
  • Huan-Min Luo
    • 1
    • 2
    • 3
    Email author
  1. 1.Department of Pharmacology, School of MedicineJinan UniversityGuangzhouChina
  2. 2.Institute of Brain SciencesJinan UniversityGuangzhouChina
  3. 3.The Joint Laboratory of Brain Function and HealthJinan UniversityGuangzhouChina

Personalised recommendations